{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:10:58Z","timestamp":1792555858675,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer AG","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiol Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40119-025-00442-4","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T09:51:57Z","timestamp":1767088317000},"page":"83-99","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study Design and Baseline Characteristics of the VERINA Study: Phase\u00a0IV Evidence of Vericiguat for Worsening Heart Failure Management"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6970-6461","authenticated-orcid":false,"given":"Jabir","family":"Abdulakutty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Abhyankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-0230","authenticated-orcid":false,"given":"Sandeep","family":"Seth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5866-2566","authenticated-orcid":false,"given":"Kamal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav","family":"Bhalani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Vijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0918-5251","authenticated-orcid":false,"given":"Rajendra Kumar Premchand","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7881-6849","authenticated-orcid":false,"given":"Suvro","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9512-1718","authenticated-orcid":false,"given":"V. K.","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0520-3566","authenticated-orcid":false,"given":"Abraham","family":"Oomman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravin","family":"Kahale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Sodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Gawde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"442_CR1","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","volume":"28","author":"NL Bragazzi","year":"2021","unstructured":"Bragazzi NL, Zhong W, Shu J. Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017. Eur J Prev Cardiol. 2021;28:1682\u201390. https:\/\/doi.org\/10.1093\/eurjpc\/zwaa147.","journal-title":"Eur J Prev Cardiol"},{"key":"442_CR2","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s43044-021-00161-w","volume":"73","author":"AA Shukkoor","year":"2021","unstructured":"Shukkoor AA, George NE, Radhakrishnan S, et al. Clinical characteristics and outcomes of patients admitted with acute heart failure: insights from a single-center heart failure registry in South India. Egypt Heart J. 2021;73:38. https:\/\/doi.org\/10.1186\/s43044-021-00161-w.","journal-title":"Egypt Heart J"},{"key":"442_CR3","doi-asserted-by":"publisher","unstructured":"Metra M, Tomasoni D, Adamo M, et al. Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2023;25(6):776\u201391. https:\/\/doi.org\/10.1002\/ejhf.2874.","DOI":"10.1002\/ejhf.2874"},{"key":"442_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1001\/jamacardio.2017.5250","volume":"3","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Mentz RJ, Felker GM. Outpatient worsening heart failure as a target for therapy. JAMA Cardiol. 2018;3:252\u20139. https:\/\/doi.org\/10.1001\/jamacardio.2017.5250.","journal-title":"JAMA Cardiol"},{"key":"442_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.59556\/japi.72.0696","volume":"72","author":"U Kaul","year":"2024","unstructured":"Kaul U, Dalal J, Hiremath J, et al. Indian experience with vericiguat: a review based upon case series. J Assoc Physicians India. 2024;72:63\u20138. https:\/\/doi.org\/10.59556\/japi.72.0696.","journal-title":"J Assoc Physicians India"},{"key":"442_CR6","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","volume":"382","author":"PW Armstrong","year":"2020","unstructured":"Armstrong PW, Pieske B, Anstrom KJ, et al. Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med. 2020;382:1883\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1915928.","journal-title":"N Engl J Med"},{"key":"442_CR7","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077.","journal-title":"N Engl J Med"},{"key":"442_CR8","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, et al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381:1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303.","journal-title":"N Engl J Med"},{"key":"442_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ahj.2017.03.019","volume":"189","author":"S Harikrishnan","year":"2017","unstructured":"Harikrishnan S, Sanjay G, Agarwal A, Kumar NP, Kumar KK, Bahuleyan CG, et al. One-year mortality outcomes and hospital readmissions of patients admitted with acute heart failure: Data from the Trivandrum Heart Failure Registry in Kerala, India. Am Heart J. 2017;189:193\u2013199. https:\/\/doi.org\/10.1016\/j.ahj.2017.03.019.","journal-title":"Am Heart J"},{"key":"442_CR10","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1002\/ehf2.14096","volume":"9","author":"S Harikrishnan","year":"2022","unstructured":"Harikrishnan S, Bahl A, Roy A, et al. Clinical profile and 90\u00a0day outcomes of 10 851\u00a0heart failure patients across India: National Heart Failure Registry. ESC Heart Fail. 2022;9:3898. https:\/\/doi.org\/10.1002\/ehf2.14096.","journal-title":"ESC Heart Fail"},{"key":"442_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jchf.2016.05.002","volume":"4","author":"SD Solomon","year":"2016","unstructured":"Solomon SD, Claggett B, Packer M, et al. Efficacy of sacubitril\/valsartan relative to\u00a0a prior decompensation: the PARADIGM-HF trial. JACC Heart Fail. 2016;4:816\u201322. https:\/\/doi.org\/10.1016\/j.jchf.2016.05.002.","journal-title":"JACC Heart Fail"},{"key":"442_CR12","doi-asserted-by":"publisher","unstructured":"Harikrishnan S, Jeemon P, Ganapathi S, et al. Five-year mortality and readmission rates in patients with heart failure in India: results from the Trivandrum heart failure registry. Int J Cardiol. 2021;326:139\u201343. https:\/\/doi.org\/10.1016\/j.ijcard.2020.10.012.","DOI":"10.1016\/j.ijcard.2020.10.012"},{"key":"442_CR13","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1016\/j.amjcard.2019.08.018","volume":"124","author":"P Pellicori","year":"2019","unstructured":"Pellicori P, Urbinati A, Kaur K, et al. Prevalence and incidence of atrial fibrillation in ambulatory patients with heart failure. Am J Cardiol. 2019;124:1554\u201360. https:\/\/doi.org\/10.1016\/j.amjcard.2019.08.018.","journal-title":"Am J Cardiol"},{"key":"442_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2025.100549","author":"R Krittayaphong","year":"2025","unstructured":"Krittayaphong R, Kaolawanich Y, Phrommintikul A, et al. The burden of atrial fibrillation and unmet needs of its management in Southeast Asia and South Asia. Lancet Region Health Southeast Asia. 2025. https:\/\/doi.org\/10.1016\/j.lansea.2025.100549.","journal-title":"Lancet Region Health Southeast Asia"},{"key":"442_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1002\/ehf2.12696","volume":"7","author":"ESJ Tan","year":"2020","unstructured":"Tan ESJ, Goh V, Santema BT, et al. Ethnic differences in atrial fibrillation among patients with heart failure in Asia. ESC Heart Fail. 2020;7:1419\u201329. https:\/\/doi.org\/10.1002\/ehf2.12696.","journal-title":"ESC Heart Fail"},{"key":"442_CR16","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/ejhf.2221","volume":"23","author":"AA Voors","year":"2021","unstructured":"Voors AA, Mulder H, Reyes E, et al. Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the VICTORIA (Vericiguat Global Study in Subjects with HFrEF) trial. Eur J Heart Fail. 2021;23:1313\u201321. https:\/\/doi.org\/10.1002\/ejhf.2221.","journal-title":"Eur J Heart Fail"},{"key":"442_CR17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.117.004406","volume":"10","author":"LA Allen","year":"2017","unstructured":"Allen LA, Fang JC. Goldilocks dilemma of dose titration in heart failure with reduced ejection fraction. Circ Heart Fail. 2017;10:e004406. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.117.004406.","journal-title":"Circ Heart Fail"},{"key":"442_CR18","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.3390\/jcm13113222","volume":"13","author":"S Okami","year":"2024","unstructured":"Okami S, Ohlmeier C, Takeichi M, et al. Vericiguat use in patients with heart failure in real-world settings during the first year after the drug authorization in Japan. J Clin Med. 2024;13:3222. https:\/\/doi.org\/10.3390\/jcm13113222.","journal-title":"J Clin Med"},{"key":"442_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.36628\/ijhf.2020.0004","volume":"2","author":"V Regitz-Zagrosek","year":"2020","unstructured":"Regitz-Zagrosek V. Sex and gender differences in heart failure. Int J Heart Fail. 2020;2:157\u201381. https:\/\/doi.org\/10.36628\/ijhf.2020.0004.","journal-title":"Int J Heart Fail"},{"key":"442_CR20","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4103\/2395-5414.182988","volume":"2","author":"V Chaturvedi","year":"2016","unstructured":"Chaturvedi V, Parakh N, Seth S, et al. Heart failure in India: the INDUS (INDia Ukieri Study) study. J Pract Cardiovasc Sci. 2016;2:28. https:\/\/doi.org\/10.4103\/2395-5414.182988.","journal-title":"J Pract Cardiovasc Sci"}],"container-title":["Cardiology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40119-025-00442-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40119-025-00442-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:26:23Z","timestamp":1773509183000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40119-025-00442-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["442"],"URL":"https:\/\/doi.org\/10.1007\/s40119-025-00442-4","relation":{},"ISSN":["2193-8261","2193-6544"],"issn-type":[{"value":"2193-8261","type":"print"},{"value":"2193-6544","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Jabir Abdulakutty, Dr. Atul Abhyankar, Dr. Sandeep Seth, Dr. Kamal Sharma, Dr. Rakesh Kumar Aggarwal, Dr. Nirav Bhalani, Dr. Vinod Vijan, Dr. Sandeep Bansal, Dr. Rajendra Kumar Premchand Jain, Dr. Suvro Banerjee, Dr. V. K. Chopra, Dr. Abraham Oomman, and Dr. Pravin Kahale declare no competing interests. Dr. Ashish Gawde and Dr. Priyanka Sodhi are employees of Bayer Pharmaceuticals Pvt Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was carried out in alignment with the protocol and established ethical principles based on international guidelines, including the Declaration of Helsinki, Council for International Organizations of Medical Sciences (CIOMS) International Ethical Guidelines, relevant International Council for Harmonisation\u2019s Good Clinical Practice (ICH GCP) Guidelines, and other applicable laws and regulations. Approval was obtained from the independent ethics committee (IEC) at each participating site (see Supplementary Material for site names and numbers). All the subjects provided informed consent to participate in the study, and also provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}